Zhiqun Shang

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 21

Top Venues

Cell death & disease

Oncogene

Clinical and translational medicine

Disease markers

This page only lists publications with an associated author ORCID identifier.

Publications

Jianpeng Yu, Minghao Zhang, Taipeng Li, Wenlong Gao, Zhao Yang, Keruo Wang, Zihao Liu, Shimiao Zhu, Simeng Wen, Yang Zhao, Qiliang Cai, Zhiqun Shang, Yong Wang, Yuanjie Niu
Monoacylglycerol lipase blockades the senescence-associated secretory phenotype by interfering with NF-κB activation and promotes docetaxel efficacy in prostate cancer. Oncogene (2024)
Jianpeng Yu, Minghao Zhang, Taipeng Li, Wenlong Gao, Zhao Yang, Keruo Wang, Zihao Liu, Shimiao Zhu, Simeng Wen, Yang Zhao, Qiliang Cai, Zhiqun Shang, Yong Wang, Yuanjie Niu
Monoacylglycerol lipase blockades the senescence-associated secretory phenotype by interfering with NF-κB activation and promotes docetaxel efficacy in prostate cancer. Oncogene (2024)
Xuanrong Chen, Yi Shao, Wanqing Wei, Shimiao Zhu, Yang Li, Yutong Chen, Hanling Li, Hao Tian, Guijiang Sun, Yuanjie Niu, Zhiqun Shang
Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer. Cell death & disease 14 (10) (2023)
Jianpeng Yu, Tianyu Shen, Yang Li, Tangxi Hao, Long Yang, Hanlin Li, Xuan-Mei Piao, Zheng Zhang, Shimiao Zhu, Changyi Quan, Wun-Jae Kim, Yang Zhao, Yuanjie Niu, Zhiqun Shang
CYTOR drives prostate cancer progression via facilitating AR-V7 generation and its oncogenic signalling. Clinical and translational medicine 13 (5) (2023)
Yang Li, Shimiao Zhu, Yutong Chen, Qianwang Ma, Duo Kan, Wenyue Yu, Boya Zhang, Xuanrong Chen, Wanqing Wei, Yi Shao, Keruo Wang, Mingpeng Zhang, Shu Deng, Yuanjie Niu, Zhiqun Shang
Post-transcriptional modification of m 6 A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer. Cell death & disease 14 (4) (2023)
Yang Li, Shimiao Zhu, Yutong Chen, Qianwang Ma, Duo Kan, Wenyue Yu, Boya Zhang, Xuanrong Chen, Wanqing Wei, Yi Shao, Keruo Wang, Mingpeng Zhang, Shu Deng, Yuanjie Niu, Zhiqun Shang
Post-transcriptional modification of m 6 A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer. Cell death & disease 14 (4) (2023)
Shimiao Zhu, Zhao Yang, Zheng Zhang, Hongli Zhang, Songyang Li, Tao Wu, Xuanrong Chen, Jianing Guo, Aixiang Wang, Hao Tian, Jianpeng Yu, Changwen Zhang, Lei Su, Zhiqun Shang, Changyi Quan, Yuanjie Niu
HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer. Cell death & disease 14 (3) (2023)
Jianpeng Yu, Tianyu Shen, Yang Li, Tangxi Hao, Long Yang, Hanlin Li, Xuan-Mei Piao, Zheng Zhang, Shimiao Zhu, Changyi Quan, Wun-Jae Kim, Yang Zhao, Yuanjie Niu, Zhiqun Shang
CYTOR drives prostate cancer progression via facilitating AR-V7 generation and its oncogenic signalling. Clinical and translational medicine 13 (5) (2023)
Shimiao Zhu, Zhao Yang, Zheng Zhang, Hongli Zhang, Songyang Li, Tao Wu, Xuanrong Chen, Jianing Guo, Aixiang Wang, Hao Tian, Jianpeng Yu, Changwen Zhang, Lei Su, Zhiqun Shang, Changyi Quan, Yuanjie Niu
HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer. Cell death & disease 14 (3) (2023)
Yang Li, Shimiao Zhu, Yutong Chen, Qianwang Ma, Duo Kan, Wenyue Yu, Boya Zhang, Xuanrong Chen, Wanqing Wei, Yi Shao, Keruo Wang, Mingpeng Zhang, Shu Deng, Yuanjie Niu, Zhiqun Shang
Post-transcriptional modification of m 6 A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer. Cell death & disease 14 (4) (2023)
Yang Li, Shimiao Zhu, Yutong Chen, Qianwang Ma, Duo Kan, Wenyue Yu, Boya Zhang, Xuanrong Chen, Wanqing Wei, Yi Shao, Keruo Wang, Mingpeng Zhang, Shu Deng, Yuanjie Niu, Zhiqun Shang
Post-transcriptional modification of m 6 A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer. Cell death & disease 14 (4) (2023)
Yang Li, Shimiao Zhu, Yutong Chen, Qianwang Ma, Duo Kan, Wenyue Yu, Boya Zhang, Xuanrong Chen, Wanqing Wei, Yi Shao, Keruo Wang, Mingpeng Zhang, Shu Deng, Yuanjie Niu, Zhiqun Shang
Post-transcriptional modification of m 6 A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer. Cell death & disease 14 (4) (2023)
Hui Xie, Linpei Guo, Qianwang Ma, Wenyi Zhang, Zhao Yang, Zhun Wang, Shuanghe Peng, Keruo Wang, Simeng Wen, Zhiqun Shang, Yuanjie Niu
YAP is required for prostate development, regeneration, and prostate stem cell function. Cell death discovery 9 (1) (2023)
Yang Li, Shimiao Zhu, Yutong Chen, Qianwang Ma, Duo Kan, Wenyue Yu, Boya Zhang, Xuanrong Chen, Wanqing Wei, Yi Shao, Keruo Wang, Mingpeng Zhang, Shu Deng, Yuanjie Niu, Zhiqun Shang
Post-transcriptional modification of m 6 A methylase METTL3 regulates ERK-induced androgen-deprived treatment resistance prostate cancer. Cell death & disease 14 (4) (2023)
Shimiao Zhu, Zhao Yang, Zheng Zhang, Hongli Zhang, Songyang Li, Tao Wu, Xuanrong Chen, Jianing Guo, Aixiang Wang, Hao Tian, Jianpeng Yu, Changwen Zhang, Lei Su, Zhiqun Shang, Changyi Quan, Yuanjie Niu
HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer. Cell death & disease 14 (3) (2023)
Boya Zhang, Mingpeng Zhang, Yanjie Yang, Qi Li, Jianpeng Yu, Shimiao Zhu, Yuanjie Niu, Zhiqun Shang
Retraction Note: Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC. Oncogene (2023)
Jianpeng Yu, Tianyu Shen, Yang Li, Tangxi Hao, Long Yang, Hanlin Li, Xuan-Mei Piao, Zheng Zhang, Shimiao Zhu, Changyi Quan, Wun-Jae Kim, Yang Zhao, Yuanjie Niu, Zhiqun Shang
CYTOR drives prostate cancer progression via facilitating AR-V7 generation and its oncogenic signalling. Clinical and translational medicine 13 (5) (2023)
Xuanrong Chen, Yi Shao, Wanqing Wei, Shimiao Zhu, Yang Li, Yutong Chen, Hanling Li, Hao Tian, Guijiang Sun, Yuanjie Niu, Zhiqun Shang
Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer. Cell death & disease 13 (11) (2022)
Boya Zhang, Mingpeng Zhang, Yanjie Yang, Qi Li, Jianpeng Yu, Shimiao Zhu, Yuanjie Niu, Zhiqun Shang
Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC. Oncogene (2021)
Zheng Zhang, Ciman Chai, Tianyu Shen, Xiaoqing Li, Junpeng Ji, Changying Li, Zhiqun Shang, Yuanjie Niu
Aberrant KIF20A Expression Is Associated with Adverse Clinical Outcome and Promotes Tumor Progression in Prostate Cancer. Disease markers 2019 (2019)
Tianyu Shen, Long Yang, Zheng Zhang, Jianpeng Yu, Liang Dai, Minjun Gao, Zhiqun Shang, Yuanjie Niu
KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells. Disease markers 2019 (2019)

Zhiqun Shang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Zhiqun Shang